Setup of a Contamination Control Strategy Using the Hazard Analysis Critical Control Point (HACCP) Methodology

References

1. 1.↵
   European Commission, Eudralex—The Rules Governing Medicinal Products in the European Union, Volume 4: Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, Annex 2, Manufacture of Biological Active Substances and Medicinal Product for Human Use. https://ec.europa.eu/health/system/files/2019-02/2018_annex2_en_0.pdf (Accessed May 2, 2022).
2. 2.↵
   International Conference on Harmonisation. Harmonised Tripartate Guideline Q10: Pharmaceutical Quality System. https://database.ich.org/sites/default/files/Q10%20Guideline.pdf (Accessed May 2, 2022).
3. 3.↵
   European Commission, Eudralex—The Rules Governing Medicinal Products in the European Union, Volume 4: Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, Annex 1: Manufacture of Sterile Medicinal Products, revised version. https://health.ec.europa.eu/system/files/2022-08/20220825_gmp-an1_en_0.pdf (Accessed February 7, 2023).
4. 4.↵
   1. Gillings N.,
   2. Hjelstuen O.,
   3. Behe M.,
   4. Decristoforo C.,
   5. Elsinga P. H.,
   6. Ferrari V.,
   7. Kiss O. C.,
   8. Kolenc P.,
   9. Koziorowski J.,
   10. Laverman P.,
   11. Mindt T. L.,
   12. Ocak M.,
   13. Patt M.,
   14. Todde S.,
   15. Walte A.

   EANM Guideline on Quality Risk Management for Radiopharmaceuticals. Eur. J. Nucl. Med. Mol. Imaging 2022, 49 (10), 3353–3364.

   OpenUrl
5. 5.↵
   International Electrotechnical Commission. International Standard IEC 60812: Analysis Techniques for System Reliability—Procedure for Failure Mode and Effects Analysis (FMEA). 2006, IEC: Geneva.
6. 6.↵
   1. Sandle T.

   Risk Assessment and Management for Healthcare Manufacturing. Practical Tips and Case Studies. PDA/DHI: Bethesda, MD, 2016; pp 1–10.
7. 7.↵
   1. Sandle T.,
   2. Leavy C.,
   3. Di Mattia M.

   Use of Hazard Analysis Critical Control Point (HACCP) Methodology for Biocontamination Control: Assessing Microbial Risks and to Determining Environmental Monitoring Locations. Eur. J. Parenter. Pharm. Sci. 2019, 24 (3), 18–45.

   OpenUrl
8. 8.↵
   World Health Organization. Annex 7—Application of Hazard Analysis and Critical Control Point (HACCP) Methodology to Pharmaceuticals; WHO Technical Report Series No. 908; WHO: Geneva, 2003. https://www.gmp-compliance.org/files/guidemgr/WHO_TRS_908_Annex7.pdf.
9. 9.↵
   European Medicines Agency. ICH Guideline Q9 on Quality Risk Management. EMA/CHMP/ICH/24235/2006. https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-3.pdf (Accessed May 3, 2022).
10. 10.↵
    1. Schmit S.

    Developing an Effective Contamination Control Strategy. Pharm. Tech. 2019, 43 (9), 57–58. http://www.pharmtech.com/developing-effective-contamination-control-strategy-0.

    OpenUrl
11. 11.↵
    1. Johnson L.,
    2. Hansy C.

    Establishing a Contamination Control Strategy/Program: From Global Development to Site Implementation. Am. Pharm. Rev. 2020, https://www.americanpharmaceuticalreview.com/Featured-Articles/564173-Establishing-a-Contamination-Control-Strategy-Program-From-Global-Development-to-Site-Implementation/ (Accessed May 20, 2022).
12. 12.↵
    1. Haddad G.,
    2. Greene A.

    Quality Risk Management Competency Model—Case for the Need for QRM Competencies. PDA J. Pharm. Sci. Technol. 2019, 73 (4), 331–344.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. El Azab W.

    Contamination Control Strategy: Implementation Road Map. PDA J. Pharm. Sci. Technol. 2021, 75 (5), 445–453.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Mascia A.,
    2. Cirafici A. M.,
    3. Bongiovanni A.,
    4. Colotti G.,
    5. Lacerra G.,
    6. Di Carlo M.,
    7. Digilio F. A.,
    8. Liguori G. L.,
    9. Lanati A.,
    10. Kisslinger A.

    A Failure Mode and Effect Analysis (FMEA)-Based Approach for Risk Assessment of Scientific Processes in Non-Regulated Research Laboratories. Accredit. Qual. Assur. 2020, 25 (5-6), 311–321.

    OpenUrl